This 100% drug-free wearable claims to relieve you from chronic pain by using pain relief technology.
Mylan CEO Heather Bresch shares her views on the pharmaceutical industry in an interview Friday on CNBC's "Power Lunch."
The drug, known as JCAR015, was being tested in adults with relapsed acute lymphoblastic leukemia, a rare and deadly blood cancer.
President Donald Trump told Congress that more needs to be done to bring down "artificially high" prices for drugs, while at the same time praising a drug that turns out to cost $300,000 per year.
CNBC's Carolin Roth discusses how the positive findings of Roche's Aphinity study is impacting investment in the business.
Amicus Therapeutics CEO Crowley is optimistic about Trump's plans to work with the pharma industry, proposing change for good.
The stock slid sharply in morning trading before rebounding to climb about 1 percent higher Wednesday.
Shares of EpiPen maker Mylan climbed on the heels of the company reporting fourth-quarter earnings that topped expectations.
A Philippine Senator and staunch critic of President Rodrigo Duterte's war on drugs was arrested on Friday.
Jim Cramer goes through his list of lightning round callers, and says it is time for Gilead to make a move.
David Ricks, Eli Lilly CEO, weighs in on tax reform priorities, border adjustment tax and drug pricing.
Feb 21- Amphastar Pharmaceuticals Inc said on Tuesday that the U.S. Food and Drug Administration had rejected its application to market an intranasal version of the emergency opioid-overdose treatment, naloxone. The Centers for Disease Control and Prevention estimates that 91 Americans die every day from opioid overdoses. Amphastar already sells...
"Drugs are becoming cheaper than candy bars. We're not going to let it happen any longer," Donald Trump said.
Chester Davis, Association for Accessible Medicines CEO weighs in on highly-priced generic drugs.
CNBC's Meg Tirrell reports the latest on how the fight over drug prices has sparked a civil war in the pharmaceutical industry, with big branded companies in one corner and the generics in the other.
By 2030, 70 percent of HIV patients will be over 50. Now success of HIV drugs poses a new challenge: treating it as a geriatric condition.
Democrat Senator Claire McCaskill on Thursday asked Kaleo Pharmaceuticals to justify the more than 550 percent surge in the price of its device to treat painkiller overdoses, becoming the second senator to question Evzio's $4,500 price tag. Privately held Kaleo has raised the price of a twin-pack to $4,500, from $690 in 2014, according to a Kaiser Health News...
David Gortler, associate professor at Georgetown University, says it is good that people are having conversations on the FDA but drug pricing remains complicated.
Amnesty International accuses Philippines President Rodrigo Duterte of putting killers on police payroll.
Jack Vitayanon, 41, allegedly had been distributing meth for several years and was seen on a video chat smoking the drug in his residence.